+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Onychomycosis Treatment Market by Treatment, Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5460360
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Onychomycosis Treatment Market grew from USD 1.92 billion in 2023 to USD 2.09 billion in 2024. It is expected to continue growing at a CAGR of 9.14%, reaching USD 3.54 billion by 2030.

Onychomycosis, commonly known as nail fungus, is a significant concern primarily affecting toenails, characterized by discoloration, thickening, and separation of the nail from the nail bed. The market for onychomycosis treatment is defined by a variety of therapeutic options, including topical and oral antifungal agents, laser therapy, and product innovations like medicated nail lacquers. The necessity for these treatments arises from the high prevalence of the condition globally, influenced by factors such as aging populations, increasing prevalence of diabetes, and a rise in awareness and access to healthcare. The primary end-users are dermatology clinics, hospitals, and homecare, with applications spanning from personal hygiene to cosmetic concerns.

Market growth is propelled by key influencing factors, such as advancements in treatment options, improved diagnosis, and increasing consumer awareness. Technological innovations, particularly in laser treatment and the development of over-the-counter products, highlight potential opportunities. Companies are recommended to capitalize on the growing demand for safe, effective, and minimally invasive treatments by investing in R&D, leveraging technology to enhance product offerings and expanding into emerging markets with a high prevalence of onychomycosis. However, market growth is challenged by factors such as high treatment costs, limited efficacy of certain treatments, and side effects associated with systemic therapies. Regulatory challenges and the need for continuous innovation also pose limitations.

The best areas for innovation include the development of new antifungal agents that offer better efficacy with fewer side effects, improving the delivery mechanisms to enhance penetration and effectiveness, and exploring nanotechnology applications. Understanding consumer preferences for non-invasive treatment options can provide insights into product development. The onychomycosis treatment market is currently experiencing a competitive yet opportunity-rich environment, characterized by rapid technological advances and evolving consumer expectations, necessitating continuous adaptation and strategic alignment with market trends for sustained growth.

Understanding Market Dynamics in the Onychomycosis Treatment Market

The Onychomycosis Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing standardization of dermatophytic onychomycosis therapeutics products
    • High prevalence of dermatophytic onychomycosis, mainly associated with diabetes
    • Increasing the cases of onychomycosis in geriatric population
  • Market Restraints
    • Availability of alternative treatment options
  • Market Opportunities
    • Development of dermatophyte strip tests
    • Rise of clinical trials in order to expand their product portfolio
  • Market Challenges
    • Lower successful ratio of drugs

Exploring Porter’s Five Forces for the Onychomycosis Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Onychomycosis Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Onychomycosis Treatment Market

External macro-environmental factors deeply influence the performance of the Onychomycosis Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Onychomycosis Treatment Market

The Onychomycosis Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Onychomycosis Treatment Market

The Onychomycosis Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Onychomycosis Treatment Market

The Onychomycosis Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Onychomycosis Treatment Market, highlighting leading vendors and their innovative profiles. These include Bausch Health Companies Inc., Bayer AG, Carise Pharmaceuticals Pvt. Ltd., Cipla Ltd, Dr. Reddys Laboratories, Galderma S.A., Galenus Pharma Pvt Ltd, Glaxo SmithKline Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Johnson & Johnson Services, Inc., Lumenis Ltd. by Boston Scientific Corporation, Medimetriks Pharmaceuticals Inc., Moberg Pharma AB, Novartis AG, and Pfizer Inc..

Market Segmentation & Coverage

This research report categorizes the Onychomycosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Treatment
    • Drugs
    • Laser Therapy
    • Photodynamic Therapy
  • Type
    • Distal Subungual Onychomycosis
    • Proximal Subungual Onychomycosis
    • White Superficial Onychomycosis
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing standardization of dermatophytic onychomycosis therapeutics products
5.1.1.2. High prevalence of dermatophytic onychomycosis, mainly associated with diabetes
5.1.1.3. Increasing the cases of onychomycosis in geriatric population
5.1.2. Restraints
5.1.2.1. Availability of alternative treatment options
5.1.3. Opportunities
5.1.3.1. Development of dermatophyte strip tests
5.1.3.2. Rise of clinical trials in order to expand their product portfolio
5.1.4. Challenges
5.1.4.1. Lower successful ratio of drugs
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Onychomycosis Treatment Market, by Treatment
6.1. Introduction
6.2. Drugs
6.3. Laser Therapy
6.4. Photodynamic Therapy
7. Onychomycosis Treatment Market, by Type
7.1. Introduction
7.2. Distal Subungual Onychomycosis
7.3. Proximal Subungual Onychomycosis
7.4. White Superficial Onychomycosis
8. Americas Onychomycosis Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Onychomycosis Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Onychomycosis Treatment Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ONYCHOMYCOSIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ONYCHOMYCOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. ONYCHOMYCOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ONYCHOMYCOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ONYCHOMYCOSIS TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY DISTAL SUBUNGUAL ONYCHOMYCOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY PROXIMAL SUBUNGUAL ONYCHOMYCOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY WHITE SUPERFICIAL ONYCHOMYCOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 23. CANADA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 25. MEXICO ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. CHINA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 37. INDIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 41. JAPAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. THAILAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 53. THAILAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 60. DENMARK ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 62. EGYPT ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. FINLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 66. FRANCE ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 68. GERMANY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. ITALY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 78. NORWAY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 80. POLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. QATAR ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 90. SPAIN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 96. TURKEY ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM ONYCHOMYCOSIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. ONYCHOMYCOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 102. ONYCHOMYCOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Onychomycosis Treatment Market, which are profiled in this report, include:
  • Bausch Health Companies Inc.
  • Bayer AG
  • Carise Pharmaceuticals Pvt. Ltd.
  • Cipla Ltd
  • Dr. Reddys Laboratories
  • Galderma S.A.
  • Galenus Pharma Pvt Ltd
  • Glaxo SmithKline Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson Services, Inc.
  • Lumenis Ltd. by Boston Scientific Corporation
  • Medimetriks Pharmaceuticals Inc.
  • Moberg Pharma AB
  • Novartis AG
  • Pfizer Inc.

Methodology

Loading
LOADING...

Table Information